Stock PRM PROTEOME SCIENCES PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Proteome Sciences plc

Equities

PRM

GB0003104196

Medical Equipment, Supplies & Distribution

Market Closed - London S.E.
Other stock markets
 11:35:28 2024-04-26 am EDT 		5-day change 1st Jan Change
4.15 GBX +18.23% Intraday chart for Proteome Sciences plc +25.76% -8.39%
Apr. 26 Proteome Sciences Wins GBP500,000 Spectrometry Services Contract in US MT
Apr. 26 Proteome wins GBP500,000 deal to supply mass spectrometry services AN

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 7.202 8.678 11.42 15.13 10.33 13.37
Enterprise Value (EV) 1 16.18 18.73 20.25 24.43 18.25 24.82
P/E ratio -5.49 x 58.9 x 38.7 x 258 x 8.14 x -5.46 x
Yield - - - - - -
Capitalization / Revenue 2.36 x 1.86 x 2.4 x 2.95 x 1.33 x 2.66 x
EV / Revenue 5.31 x 4.02 x 4.26 x 4.76 x 2.35 x 4.94 x
EV / EBITDA -14.2 x 55.7 x 34.9 x 54 x 9.95 x -16.6 x
EV / FCF -32.2 x -31.1 x 19.6 x 76.9 x 25.2 x -43.1 x
FCF Yield -3.1% -3.22% 5.11% 1.3% 3.97% -2.32%
Price to Book -1.89 x -2.38 x -3.4 x -5.45 x -12.3 x -4.36 x
Nbr of stocks (in thousands) 295,182 295,182 295,182 295,182 295,182 295,182
Reference price 2 0.0244 0.0294 0.0387 0.0512 0.0350 0.0453
Announcement Date 4/4/19 4/20/20 4/8/21 4/14/22 4/3/23 4/20/24
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3.049 4.656 4.753 5.129 7.78 5.028
EBITDA 1 -1.141 0.336 0.581 0.452 1.834 -1.498
EBIT 1 -1.37 0.299 0.549 0.412 1.728 -1.621
Operating Margin -44.93% 6.42% 11.55% 8.03% 22.21% -32.24%
Earnings before Tax (EBT) 1 -1.659 -0.036 0.245 0.118 1.255 -2.418
Net income 1 -1.313 0.149 0.295 0.072 1.325 -2.443
Net margin -43.06% 3.2% 6.21% 1.4% 17.03% -48.59%
EPS 2 -0.004448 0.000499 0.000999 0.000199 0.004299 -0.008299
Free Cash Flow 1 -0.5022 -0.6031 1.035 0.3178 0.7254 -0.5762
FCF margin -16.47% -12.95% 21.78% 6.2% 9.32% -11.46%
FCF Conversion (EBITDA) - - 178.2% 70.3% 39.55% -
FCF Conversion (Net income) - - 350.97% 441.32% 54.75% -
Dividend per Share - - - - - -
Announcement Date 4/4/19 4/20/20 4/8/21 4/14/22 4/3/23 4/20/24
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 8.98 10 8.83 9.3 7.92 11.4
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -7.869 x 29.9 x 15.19 x 20.58 x 4.319 x -7.642 x
Free Cash Flow 1 -0.5 -0.6 1.04 0.32 0.73 -0.58
ROE (net income / shareholders' equity) 41.2% -3.99% -8.42% -2.35% -73.2% 125%
ROA (Net income/ Total Assets) -11.8% 2.43% 3.93% 2.69% 9.61% -8.48%
Assets 1 11.12 6.135 7.503 2.676 13.79 28.8
Book Value Per Share 2 -0.0100 -0.0100 -0.0100 -0.0100 -0 -0.0100
Cash Flow per Share 2 0 0 0.0100 0.0100 0.0100 0.0100
Capex 1 0 0.06 0.01 0.2 0.32 0.24
Capex / Sales 0.13% 1.25% 0.27% 3.98% 4.1% 4.71%
Announcement Date 4/4/19 4/20/20 4/8/21 4/14/22 4/3/23 4/20/24
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
PROTEOME SCIENCES PLC Stock Proteome Sciences plc
-8.39% 15.26M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. PRM Stock
  4. Financials Proteome Sciences plc